Monograph Title | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication Sort descending | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
HOMATROPINE HYDROBROMIDE | CHEMICAL INFORMATION | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | Change 356.25 to: 356.26 AND Change 1αH,5αH-Tropan-3α-ol mandelate (ester) hydrobromide to: (1R,3r,5S)-8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2-phenylacetate hydrobromide |
LYSINE HYDROCHLORIDE | IMPURITIES/Related Compounds | USPNF Online | Online | 16-Dec-2022 | 1-Jun-2023 | NA | NA | In Chromatographic system/Spray reagent: Change 0.2 g of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) to: 2 mg/mL of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) |
LINEZOLID TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | In Sensitivity solution: Change 0.5 ug/mL of USP Linezolid RS from Standard solution in Diluent to: 0.5 μg/mL of USP Linezolid RS from Standard solution in Diluent |
AMOXICILLIN BOLUSES | IDENTIFICATION | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | Change Application volume, Developing solvent system, Procedure—Proceed as directed for the Identification test under Amoxicillin Tablets. to: Application volume—5 µL. Developing solvent system… Read More |
BROMOCRIPTINE MESYLATE CAPSULES | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 29-Apr-2022 | 1-May-2022 | NA | NA | In Analysis: Change bromocriptine mesylate (C32H40BrN5O5 · CH4SO3) to: bromocriptine (C32H40BrN5O5) AND In… Read More |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In System suitability solution: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS AND In Standard solution: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-… Read More |
THYROID | ASSAY/Procedure | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Chromatographic system: Change Column: 4.6-cm × 25-cm; packing L1 to: Column: 4.6-mm × 25-cm; packing L1 |
BLACK CUMIN SEED THYMOQUINONE OIL | DEFINITION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | Change carvacol to: carvacrol |
ENSULIZOLE | IDENTIFICATION | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In B.: Change The retention time of the major peak of the Sample solution exhibits maxima and minima at the same wavelengths as those of the Standard solution, as obtained in the Assay. to: The retention time of the major… Read More |
DOFETILIDE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change β-[(p-Methanesulfonamidophenethyl)methylamino]methane sulfono-p-phenetidide to: N-{4-[2-(Methyl{2-[4-(methylsulfonamido)phenoxy]ethyl}amino)ethyl]phenyl}methanesulfonamide |
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change USP 2-Methylbenzhydrol RS to: USP Methylbenzhydrol RS |
ZIPRASIDONE CAPSULES | IMPURITIES | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Organic Impurities/Solution B: Change potassium hydroxide to: potassium hydroxide solution AND In Organic Impurities/Analysis: Change 449.40 to: 449.39 |
LATANOPROST | ASSAY/Procedure | USPNF Online | Online | 29-Jul-2022 | 1-Dec-2022 | NA | NA | Change Standard solution: Transfer 2.0 mg/mL of USP Latanoprost RS into a suitable volumetric flask, dissolve in dehydrated alcohol equivalent to 20% of the final volume, and dilute with chromatographic hexane to volume. Sample solution:… Read More |
CHLOROPROCAINE HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Sample solution: Change Transfer about 100 mg of chloroprocaine hydrochloride to a 100-mL volumetric flask, dissolve in 40 mL of methanol, and dilute with water to volume. to: Transfer a volume of Injection, equivalent to about 100 mg of… Read More |
TIOCONAZOLE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In USP Tioconazole Related Compound A RS: Change 389.73 to: 389.72 AND In USP Tioconazole Related Compound B RS: Change 458.62 to: 458.60 AND In USP Tioconazole Related Compound C RS: Change C16H13BrCl2… Read More |
CEFDINIR | IMPURITIES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Organic Impurities/Table 2/footnote a: Change 1N-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetyl]glycine. to: N-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetyl]glycine. |
DOXYCYCLINE HYCLATE | CHEMICAL INFORMATION | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change 1025.87 to: 1025.88 |
DOXYCYCLINE HYCLATE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
ADIPIC ACID | IMPURITIES/Related Substances | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Table 2: Change Pimelic acid 1.21 0.91 Valeric acid 1.21 0.91 to: Pimelic acid 1.21 0.91 Valeric acid 1.46 0.88 |
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES | IDENTIFICATION | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change A. The UV-Vis spectrum of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. to: A. The UV spectrum of the major peak of the Sample solution… Read More |
UREA | SPECIFIC TESTS | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Alcohol-Insoluble Matter/Sample solution: Change 100 mg/mL of Urea dissolved in warm alcohol to: Dissolve 5.0 g of Urea in 50 mL of warm alcohol. AND In Alcohol-Insoluble Matter/Analysis: Change If any insoluble… Read More |
POWDERED VALERIAN EXTRACT | DEFINITION | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | Change calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid, on the dried basis. to: calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid, on the anhydrous basis. |
<467> RESIDUAL SOLVENTS | USP REFERENCE STANDARDS <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change USP Residual Solvent Class 2—Mixture C RS to: USP Residual Solvents Class 2—Mixture C RS |
SOTALOL HYDROCHLORIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | In Analysis: Change Calculate the percentage of any unspecified impurities in the portion of Sotalol Hydrochloride taken: Result = (rU/rS) × (CS/CU) × 100 r… Read More |
CLOMIPHENE CITRATE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | NA | In Table 2: Change Clomiphene related compound A 0.87 – 2.0 to: Clomiphene related compound A 0.87 1.0 2.0 |
LINEZOLID TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | In Dissolution 〈711〉/Test 1/Analysis: Change Result = (rU/rS) × CS × V × (1/L) × 100 rU = peak response of linezolid from the Sample… Read More |
MELENGESTROL ACETATE | CHEMICAL INFORMATION | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | Change 396.52 to: 396.53 |
LYSINE ACETATE | IMPURITIES/Related Compounds | USPNF Online | Online | 16-Dec-2022 | 1-Jun-2023 | NA | NA | In Chromatographic system/Spray reagent: Change 0.2 g of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) to: 2 mg/mL of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) |
MILBEMYCIN OXIME | CHEMICAL INFORMATION | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | Change 541.68 Milbemycin B, 5-O-demethyl-28-deoxy-25-methyl-6,28-epoxy-23-hydroxyimino-, [6R,23S,25S(E)]-; (2αE,4E,5′S,6R,6′S,8E,11R,13R,15S,17αR,… Read More |
AMOXICILLIN INTRAMAMMARY INFUSION | IDENTIFICATION | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | Change The solution obtained responds to the Identification test under Amoxicillin Capsules. to: Prepare a Standard solution of USP Amoxicillin RS in 0.1 N hydrochloric acid containing 4 mg per mL. Use within 10 minutes after preparation.… Read More |
ACYCLOVIR | ASSAY/Procedure | USPNF Online | Online | 29-Apr-2022 | 1-May-2023 | NA | NA | In the Sample solution: Change 0.1 N sodium hydroxide to: 0.01 N sodium hydroxide |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | IMPURITIES/Related Compounds | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change CS = concentration of USP Calcium DL-5-Methyltetrahydrofolate RS in the Standard solution (mg/mL) to: CS = concentration of USP Calcium D,L-5-Methyltetrahydrofolate RS in the … Read More |
THYROID TABLETS | ASSAY/Procedure | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Chromatographic system: Change Column: 4.6-cm × 25-cm; packing L1 to: Column: 4.6-mm × 25-cm; packing L1 |
BLACK CUMIN SEED THYMOQUINONE OIL | SPECIFIC TESTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Fats and Fixed Oils 〈401〉, Procedures, Fatty Acid Composition/Table 2: Change Linoleic to: Linoleic acid |
IPRATROPIUM BROMIDE INHALATION SOLUTION | IMPURITIES | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In Organic Impurities: Change Column: 4.6-mm × 25-µm; 5-µm packing L1 to: Column: 4.6-mm × 25-cm; 5-µm packing L1 |
DOXYCYCLINE HYCLATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Table 2, footnote b: Change (4S,4aR,5S,5aR,6R,12aS)-2-Acetyl-4-(dimethylamino)-4a,5a,6,12a-tetrahydro-3,5,10,12,12a-pentahydroxy-6-methyl-tetracene-1,11-dioxo-2-naphthacenecarboxamide. to: (4S,4aR,5S,5a… Read More |
PRIMIDONE TABLETS | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Dec-2022 | NA | NA | In Sample solution: Change 0.05 mg/mL of primidone from the Standard stock solution in Diluent to: 0.05 mg/mL of primidone from the Sample stock solution in Diluent |
ROSEMARY | COMPOSITION/Content of Phenolic Diterpenes | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Sample solution: Change Before injection, pass through a membrane filter of 0.45-µL or finer pore size, to: Before injection, pass through a membrane filter of 0.45-µm or finer pore size, |
ZIPRASIDONE HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Organic Impurities/Solution B: Change Acetonitrile, methanol, and Buffer (55:5:40). Adjust with potassium hydroxide TS to a pH of 6.0. to: Acetonitrile, methanol, and Buffer (55:5:40). Adjust with potassium hydroxide solution… Read More |
<659> PACKAGING AND STORAGE REQUIREMENTS | GENERAL DEFINITIONS/Packaging Definitions | Second Supplement to USP43–NF38 | Online | 26-Mar-2021 | 1-Dec-2025 | NA | NA | In Light-resistant container: Change 〈661.2〉, Functionality, Spectral Transmission Requirements for Light-Resistant Components and Systems. to: 〈661.2〉, Functionality Test Method, Spectral Transmission Requirements for Light-… Read More |
METHSUXIMIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In System suitability/Column efficiency: Change NTL 5800 theoretical plates to: NLT 5800 theoretical plates |
POTASSIUM GLUCONATE ORAL SOLUTION | SPECIFIC TESTS | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change Alcohol Determination 〈611〉, Method II—Distillation Method: to: Alcohol Determination 〈611〉, Method I—Distillation Method: |
METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | Change USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS (USP Methacrylic Acid Copolymer, Type C RS) to: USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS (USP Methacrylic Acid Copolymer Type C RS) |
CEFDINIR | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 |
ASCORBIC ACID INJECTION | ASSAY/Procedure | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In Chromatographic system/Column: Change 150-cm × 6-mm; packing L39 to: 15-cm × 6-mm; packing L39 |
POTASSIUM CITRATE EXTENDED-RELEASE TABLETS | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Test 6: Change Times: 0.5, 1, and 4 h—for strengths 540 and 1080 mg as potassium citrate monohydrate; 0.5, 1, and 6 h—for strength 1620 mg as potassium citrate monohydrate. to: Times: 0.5, 1, and 4 h—for strength 540 mg as potassium… Read More |
FLUTICASONE PROPIONATE NASAL SPRAY | OTHER COMPONENTS/Content of Phenylethyl Alcohol | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Sample solution: Change Transfer 1.0 g of the Nasal Spray to a 50-mL volumetric flask. Add about 40 mL of Diluent, and sonicate for 10 min until the supernatant is clear. Use the clear supernatant for analysis. to: Transfer 1.0 g of the… Read More |
PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS | ASSAY | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Procedure/System suitability/Tailing factor: Change NMT 2.0, System suitability solution to: NMT 2.0 for pantoprazole, System suitability solution |
POWDERED VALERIAN EXTRACT | COMPOSITION/Content of Valerenic Acids | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In Acceptance criteria: Change calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid on the dried basis to: calculated as the sum of hydroxyvalerenic acid, acetoxyvalerenic acid, and valerenic acid on the anhydrous… Read More |
METHYLENE BLUE | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In footnote a in Table 2: Change 3-(Dimethylamino)-7-(methylamino)-phenothiazine-5-ium chloride. to: 3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride. |